UPDATE 1-Stallergenes proposes merger proposal with U.S. partner
March 03, 2015 at 15:57 PM EST
PARIS, March 3 (Reuters) - Stallergenes' controlling shareholder proposed merging the French pharmaceuticals group's operations with its U.S. partner Greer to create a specialist in allergy immunotherapy with combined sales of 330 million euros ($368.78 million).
